Arvinas (ARVN) Assets Average (2018 - 2026)
Arvinas (ARVN) recorded quarterly Assets Average of $682.7 million in Q1 2026, down 12.6% quarter-over-quarter from $781.1 million in Q4 2025, and down 34.75% on a YoY basis from $1.0 billion in Q1 2025.
Arvinas (ARVN) Assets Average (2018 - 2026) Analysis & Trends
Arvinas' Assets Average history runs 9 years deep, the most recent figure standing at $682.7 million for Q1 2026.
- In Q1 2026, Assets Average fell 34.75% year-over-year to $682.7 million; the TTM figure through Mar 2026 stood at $682.7 million (down 34.75% YoY), while the FY2025 annual figure was $904.6 million, down 24.49% from the prior year.
- Assets Average was $682.7 million for Q1 2026 at Arvinas, down from $781.1 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $1.5 billion in Q1 2022 to a low of $682.7 million in Q1 2026.
- Historically, Assets Average has averaged $1.1 billion across 5 years, with a median of $1.2 billion in 2023.
- The sharpest annual moves came in 2022 and 2026: Assets Average surged 119.41% in 2022, then slumped 34.75% in 2026.
- A 5-year view of Assets Average shows it stood at $1.3 billion in 2022, then fell by 9.24% to $1.2 billion in 2023, then slipped by 4.42% to $1.1 billion in 2024, then sank by 30.83% to $781.1 million in 2025, then slipped by 12.6% to $682.7 million in 2026.
- The last three Assets Average figures came in at $682.7 million (Q1 2026), $781.1 million (Q4 2025), and $876.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - | 682.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 682.70 Mn |
| Dec 31, 2025 | 781.10 Mn |
| Sep 30, 2025 | 876.80 Mn |
| Jun 30, 2025 | 955.20 Mn |
| Mar 31, 2025 | 1.05 Bn |
| Dec 31, 2024 | 1.13 Bn |
| Sep 30, 2024 | 1.22 Bn |
| Jun 30, 2024 | 1.25 Bn |
| Mar 31, 2024 | 1.26 Bn |
| Dec 31, 2023 | 1.18 Bn |
| Sep 30, 2023 | 1.07 Bn |
| Jun 30, 2023 | 1.13 Bn |
| Mar 31, 2023 | 1.22 Bn |
| Dec 31, 2022 | 1.30 Bn |
| Sep 30, 2022 | 1.37 Bn |
| Jun 30, 2022 | 1.45 Bn |
| Mar 31, 2022 | 1.53 Bn |
| Dec 31, 2021 | 1.59 Bn |
| Sep 30, 2021 | 1.12 Bn |
| Jun 30, 2021 | 662.90 Mn |